Skip to main content
. 2016 Jan 14;273(10):3287–3291. doi: 10.1007/s00405-016-3897-5

Table 1.

Results relating to question about indications for screening for distant metastases

Indication Responders Specifications
2005 (n = 19) 2015 (n = 8) 2005 2015
Lymph node metastasis 12/19 (63 %) 8/8 (100 %) ≥N2b, levels, IV–V, supraclavicular See Table 2
Extremely mutilating surgical intervention 11/19 (58 %) 5/8 (63 %)
Local and/or regional recurrence 9/19 (47 %) 4/8 (50 %)
T-stage 3–4 6/19 (32 %) 1/8 (13 %)
Second primary head and neck cancer 4/19 (21 %) 3/8 (38 %)